Mesalamine Capsule, Extended Release — FDA Drug Shortage

To Be Discontinued — Takeda Pharmaceuticals USA Inc.

The FDA lists a drug shortage record for Mesalamine Capsule, Extended Release (capsule, extended release) from Takeda Pharmaceuticals USA Inc. with status To Be Discontinued. The shortage was first posted on Sep 16, 2026.

Shortage details

Status
To Be Discontinued
Company
Takeda Pharmaceuticals USA Inc.
Package NDC
54092-189-81
Dosage Form
Capsule, Extended Release
Presentation
Pentasa, Capsule, Extended Release, 250 mg (NDC 54092-189-81)
Initial Posting
Sep 16, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.